Director, Operational Team, WIN Consortium

Chief Scientific and Operating Officer, WIN Consortium

Chief Medical Officer, WIN Consortium

Chair, Clinical Trials Committee, WIN Consortium; Senior Medical Oncologist, Institut Curie (France)

Chair/Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Senior adviser to WIN Strategy, Science and Fundraising, WIN Consortium

Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)

Chair, Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Director, Operational Team, WIN Consortium

Chief Scientific and Operating Officer, WIN Consortium

Assistant, Operational Team, WIN Consortium

IT Data Manager, WIN Consortium

Senior adviser to WIN Strategy, Science and Fundraising, WIN Consortium

Head of Bioinformatics, WIN Consortium; Senior Lecturer, Ben-Gurion University of the Negev (Israel)

Data Manager, WIN Consortium

Project Manager, WIN Consortium

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Head of Laboratory for Clinical Genomic Bioinformatics; Head of Genomic Center; Sechenov First Moscow Medical University (Russia)

Chair of Department of Systems Biology, Columbia University (USA)

Chief Medical Officer and Senior Vice President, Clinical Genomics, Illumina (USA)

Professor, Medicine-Computational Biomedicine and Biomedical Data Science, University of Chicago (USA)

Vice Chair, Scientific Advisory Board, WIN Consortium; Chair and Professor, Department of Pathology, City of Hope Comprehensive Cancer Center (USA)

Professor of Pathology, Nice Sophia Antipolis University (France)

Director, Lowe Center for Thoracic Oncology and Scientific Director, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (USA)

Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)

Professor, Computational Biology and Bioinformatics and Chair, Dept of Biostatistics, Harvard T.H Chan School of Public Health and Professor at Dana-Farber Cancer Institute (USA)

Head, Sheba Cancer Research Center, Chaim Sheba Medical Center (Israel)

Director of the Quantitative Sciences Program and Biostatistics/Bioinformatics Division, Department of Oncology, John Hopkins Medicine (USA)

Chief, Cancer Data Science Laboratory, National Institute of Health (NIH), USA

Senior Scientist, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada)

Professor, Weizmann Institute of Science (Israel)

Vice President, Fudan University Shanghai Cancer Center (China)

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Head of Digestive Oncology department, Gustave Roussy (France)

Head of Department, Medical Oncology, Institut Curie (France)

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Chair/Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Associate Director, Medical Affairs - Oncology, Illumina (USA)

Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Head of Medical Oncology, Groupe Hospitalier Paris Saint-Joseph (France)

Head of Bioinformatics, WIN Consortium; Senior Lecturer, Ben-Gurion University of the Negev (Israel)

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)

Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)

Chair, Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Asst Professor of Medicine, Avera Cancer Institute (USA)

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)

Chief Medical Officer, Chief Medical officer and Deputy Director General King Hussein Cancer Center (Jordan)

Chief Scientific Officer, King Hussein Cancer Center (Jordan)

Head of Research and Professor in Department of Medical Oncology, Gustave Roussy (France)

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Head of Medical Oncology department, Centre Hospitalier de Luxembourg; Associate Medical Director, Luxembourg Institute of Health (Luxembourg)

Director, Institute of Oncology, Sheba Medical Center (Israel)

Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Professor of Medicine, Université Claude Bernard; Scientific Director, Canceropole Lyon Rhône Alpes, Centre Léon Bérard (France)

Head of Pathology, The Oncology Institute Ion Chiricuta (IOCN) (Romania)

Rector, The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)

Deputy Director of Clinical Research, Instituto Nacional de Cancerologia (INCan)(Mexico)

Scientific Director, INCLIVA (Spain)

Vice President, Fudan University Shanghai Cancer Center (China)

Past President, Chair of the Scientific Committee, European Cancer Patient Coalition - ECPC (Belgium)

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Head of Digestive Oncology department, Gustave Roussy (France)

Director General, Fondation ARC (France)

Senior Vice-President IMED Oncology, AstraZeneca (USA)

Head of Unit CIEC & CPMO, Clinical and Epidemiological Investigation Center, Luxembourg Institute of Health (Luxembourg)

VP, R&D Clinical Excellence and Head of Clinical, Late Oncology, AstraZeneca (United Kingdom)

Head of Department, Medical Oncology, Institut Curie (France)

Medical Oncologist, Instituto Valenciano de Oncología (IVO)(Spain)

Associate Professor, Deputy Director, Tokyo Medical and Dental University Cancer Center (Japan)

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Senior Vice President and Chief Commercial Officer, HTG Molecular (USA)

Head of Laboratory, Molecular Biologist and Geneticist, Instituto Valenciano de Oncología (IVO)(Spain)

Consultant Medical Oncologist Melanoma, Sarcoma and GU Tumors Unit Early Drug Development Unit, Catalan Institute of Oncology (ICO)(Spain)

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Director, Tokyo Medical and Dental University Cancer Center (Japan)

Associate Professor, Oncology Department, Hadassah Hebrew University Medical School (Israel)

Professor and Head of Centre for Genomic Medicine, Rigshospitalet (Denmark)

Chair/Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Associate Director, Medical Affairs - Oncology, Illumina (USA)

Chairman of the Board of directors, Institut Curie (France)

Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Chairman, Hadassah Medical Center (Israel)

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Head of Medical Oncology, Groupe Hospitalier Paris Saint-Joseph (France)

Executive and Scientific Director, Research and Education Institute, Coordinator, Molecular Oncology Research Center, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Head of Bioinformatics, WIN Consortium; Senior Lecturer, Ben-Gurion University of the Negev (Israel)

Executive Director, SURVIVEiT (USA)

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)

Head of Medical Oncology Department, Catalan Institute of Oncology (ICO)(Spain)

Chair, Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Professor, Medical Oncology - Tata Memorial Center (India)

Asst Professor of Medicine, Avera Cancer Institute (USA)

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

First Vice Rector for Innovation and International Affairs, I.M Sechenov First Moscow State Medical University (Russia)

Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Global Market Development, Illumina (USA)

Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)